The strike price is bewildering for sure but to be honest, the way we are travelling the share price doesnt look like lifting anytime soon so he may never be able to convert them!
But in all seriousness a good appointment that will add more strength to pushing our products forward. The company must be gearing up for a push to get remplir established in the U.S. market sooner rather than later.
Ann: Orthocell Appoints Non-Executive Director Dr Ravi Thadhani, page-9
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
